69
Masquerade Syndrome DR R PATEL ame the common syndromes that masquerade as anterior and posterior nd their diagnostic tests. 5+5 PAPER III DNB question Papers 2011 (

Masquerade Syndrome

Embed Size (px)

Citation preview

Page 1: Masquerade Syndrome

Masquerade Syndrome

DR R PATEL

Name the common syndromes that masquerade as anterior and posterior uveitis and their diagnostic tests. 5+5 PAPER III DNB question Papers 2011 (June)

Page 2: Masquerade Syndrome

Masquerade Syndrome Group of disorders simulating/mimic Ant. Or Post. Uveitis in their

C/F but are having entirely diff. etiopathogenesis being usually neoplastic or occasionally ischaemic

1967 :Theodore : used the term "Masquerade Syndrome" in ophthalmology to describe a case of conjunctival carcinoma that manifested as chronic conjunctivitis

Many are malignant; prompt dx needed.

Uveitis Masquerade accounts for 5 % of patients with uveitis in a tertiary care centre

Page 3: Masquerade Syndrome

When to suspect ?

Masquerade syndromes should be considered : In the very young and in the elderly. with persistent idiopathic uveitis that is nonresponsive to corticosteroids

Page 4: Masquerade Syndrome

Masquerade Syndromes Anterior Segment

Retinoblastoma Leukemia IOFB Malignant Melanoma JXG (Juvenile

xanthogranuloma) Peripheral RD

Posterior Segment Retinitis pigmentosa Reticulum Cell

Sarcoma Lymphoma Malignant Melanoma MS

Page 5: Masquerade Syndrome

Masquerade syndromes Lymphoid malignancies

i. Lymphoma ii. Leukemia

Nonlymphoid malignancies i.Uveal melanoma i. Choroidal metastasis ii. Paraneoplastic syndromes

CAR(carcinoma-associated retinopathy)

MAR Bilateral diffuse uveal

melanocytic proliferation iv. Retinoblastoma v. Juvenile xanthogranuloma Vi .Medulloepitheliom

Nonneoplastic a. Chronic peripheral retinal

detachment b. Retinitis pigmentosa c. Intraocular foreign body d. Amyloidosis e. Vitreous hemorrhage f. Retinal vascular disease

i. Ocular ischemic syndrome ii. Hypertensive retinopathy iii. Diabetic retinopathy iv. Vascular occlusion

g. Coats diseasea

Page 6: Masquerade Syndrome

Frequency of masquerade syndromes upon referral

Malignancy type Lymphoma (13) Leukemia (3) Melanoma (1) Metastasis (1) Retinoblastoma (1)

Nonmalignancy Retinal vascular disease

(10) Retinal Detachment (2) Coats' Disease (1) Other (8)

Page 7: Masquerade Syndrome

INTRAOCULAR LYMPHOMA :INTRODUCTION

Synonyms : large B-cell lymphoma, reticulum cell sarcoma.

The most common neoplastic masquerader(68%) NHL involving eye is a rare cond. Which mimics ch.

Uveitis or post. Uveitis Ocular lymphomas occur in both primary &

secondary forms Site of origin of PCNSL is unknown Yet are able to grow only in these two

immunologically sequestered locations (CNS or eye)

Page 8: Masquerade Syndrome

CLASSIFICATION of Lymphoma

1 Hodgkin disease may cause anterior uveitis, vitritis, and multifocal fundus lesions

resembling chorioretinitis. 2 Non-Hodgkin lymphoma may cause

conjunctival involvement, orbital involvement, Mikulicz syndrome and uveal infiltration.

3 CNS B-cell lymphoma may be associated with intermediate uveitis and sub-RPE infiltrates.

4 Primary intraocular lymphoma (PIOL) represents a subset of primary central nervous system

lymphoma (PCNSL

Page 9: Masquerade Syndrome

Intraocular Lymphoma

Intraocular lymphoma can masquerade as a chronic infection and may be a sign of CNS malignancy.

Etiopathogenesis Malignant infiltration of choroid by

lymphomatous cells.

Page 10: Masquerade Syndrome

PRIMARY INTRAOCULAR LYMPHOMA

Demographics Fifty to sixty years of age.

Ocular manifestations – Presentation unilateral floaters blurred vision red eye photophobia, which frequently becomes

bilateral after a variable interval.

Page 11: Masquerade Syndrome

Intraocular Lymphoma :Signs

Mild anterior uveitis with cells, flare and keratic precipitates.

Vitritis: impede visualization of the fundus. Large solid multifocal subretinal infiltrates Occasionally coalescence of sub-RPE deposits may form a ring

encircling the equator Other features include

retinal vasculitis, vascular occlusion, exudative retinal detachment and optic atrophy.

Lack of CMO is an important diagnostic clue, since in true uveitis significant vitritis is almost always accompanied by CMO.

Page 12: Masquerade Syndrome

Anterior segment of the eye of a patient with biopsy-prove intraocular large-cell lymphoma demonstrating corneal keratitic precipitates

Slit-lamp biomicroscopy examination revealing sheets ofvitreous cells characteristic of intraocular lymphoma

Page 13: Masquerade Syndrome

Vitritis in patient with intraocular lymphoma. universal finding

Page 14: Masquerade Syndrome

Multifocal subretinal infiltrates Shallow retinal detachment

Page 15: Masquerade Syndrome

Infiltration of transformed peripheral T-cell lymphoma into the iris

Page 16: Masquerade Syndrome

Subretinal infiltration of lymphoma cells

Page 17: Masquerade Syndrome

Fundus photograph of patient with intraocular lymphomashowing retinal infiltrates and hemorrhage mimicking Cytomegalovirus retinitis.

Page 18: Masquerade Syndrome

Obstructive hydrocephalus and cerebral lymphoma

Optic disc edema in human immunodeficiency virus-positive patient

Page 19: Masquerade Syndrome

Chorioretinal infiltration of primary ocular and CNS large B-cell NHL

Masquerading as multifocal chorioretinitis

Page 20: Masquerade Syndrome
Page 21: Masquerade Syndrome

PATHOLOGY

Thickening of detatched retina ( Pizza-Pie appearance )

Subretinal pigment elevation Vitreous infiltration FA shows blockage with a

granular characteristic, due to the presence of sub-RPE accumulation of lymphomatous cells (leopard skin spots).

Page 22: Masquerade Syndrome

Intraocular Lymphoma Systemic Findings

Behavioral changes hemiparesis Ataxia

Special Tests MRI. Lumbar puncture. Vitreous biopsy for cytology, flow cytometry, interleukin-6 and -10, immunoglobulin heavy chain gene rearrangement.

Treatment and Management Radiation therapy. Chemotherapy (intrathecal methotrexate or cytosine arabinoside [ara-C]) . Biologic agents involving specific anti-B cell monoclonal antibodies (such as rituximab

Initial workup may be negative, but maintain a high clinical suspicion in uveitis refractory to treatment.

Page 23: Masquerade Syndrome

MR image showing a hypointense multifocal lesion

Page 24: Masquerade Syndrome

SYSTEMIC LYMPHOMA

Epidemiology Rare intraocular involvement, older adults

Ocular Manifestations: Vitreitis, retinal vasculitis, necrotizing retinitis, diffuse

choroiditis, focal uveal masses, AU, hypopyon Systemic Associations:

Lymphadenopathy, involvement of retroperitoneum, paranasal sinuses, orbits, meninges, bone marrow

Comments: ocular involvement may be initial sign average longevity of 31 months following ocular diagnosis

Page 25: Masquerade Syndrome

RETINOBLASTOMA

Most common primary, malignant, intraocular tumour of childhood (1:20,000)

No sexual predilection Presents before age of 3 years (average 3

months) Heritable (40%) or non-heritable (60%) Predisposing gene (RPE 1) on 13q14 AU(1–3%), vitreitis, shifting white hypopyon

Page 26: Masquerade Syndrome

Leukocoria - 60% Strabismus - 20% Secondary glaucoma

• Anterior segment invasion • Orbital inflammation • Orbital invasion

Presentations of retinoblastoma

Page 27: Masquerade Syndrome

Early endophyliticretinoblastoma

White flat lesion Placoid lesion

Page 28: Masquerade Syndrome

More advanced endophytic retinoblastoma

Friable white mass Cottage cheese appearance

Fine surface blood vessels Vitreous seedings

Page 29: Masquerade Syndrome

Exophytic retinoblastoma

Multiglobulated white mass withoverlying retinal detachment

May be difficult to visualize through deep detachment

Page 30: Masquerade Syndrome

Occasionally, tumor necrosis may produce significant inflammation.

Page 31: Masquerade Syndrome

Right eye showing pseudo-hypopyon and tumour infiltrating the iris.

Page 32: Masquerade Syndrome

Pseudohypopyon was an unusual first sign of retinoblastoma in a 6-year-old girl without a positive family history

Page 33: Masquerade Syndrome

RETINOBLASTOMA

Investigations Ultrasound, aqueous tap USG, CT, MRI, Bonemarrow aspiration, lumbar

puncture Calcification(75%) on ultrasonography and CT

scan may help to differentiate retinoblastoma from various forms of childhood uveitis (toxoplasmosis, toxocariasis, cysticercosis, and pars planitis)

Page 34: Masquerade Syndrome

CT diagnosis of retinoblastoma

Calcification

• Optic nerve involvement

• Orbital and CNS extension

• Pinealoblastoma

Page 35: Masquerade Syndrome

Treatment Options of Retinoblastoma1. Small tumours

• Laser photocoagulation• Transpupillary thermotherapy• Cryotherapy

2. Medium tumours • Brachytherapy• Chemotherapy• External beam radiotherapy

3. Large tumours • Chemotherapy followed by local treatment• Enucleation

4. Extraocular extension• External beam radiotherapy

5. Metastatic disease• Chemotherapy

Page 36: Masquerade Syndrome

CILIARY BODY MELANOMA

10% of uveal melanomas C/F 6 th decade Dilated episcleral vessels in same quadrants

(Sentinel vessels ) Astigmatism, Subluxation, Cataract RD Necrotic tumors may elicit an intense inflammatory

response associated with seeding of tumor cells into the vitreous cavity and anterior segment

Page 37: Masquerade Syndrome

Ciliary body melanoma

• Rare - 12% of uveal melanomas

• Presentation - 6th decade

• May be discovered by chance

• Prognosis - guarded

Page 38: Masquerade Syndrome

Signs of ciliary body melanoma

• Sentinel vessels • Extraocular extension

• Erosion through iris root • Lens subluxation or cataract• Retinal detachment

Page 39: Masquerade Syndrome

CILIARY BODY MELANOMA

C/F Ant. Uveitis Investigations –

Tripple mirror contact lens, Transillumination, Ultrasonic biomicroscopy, Biopsy

Infiltration of malignant melanoma into the iris

Keratic precipitates, occasional intraocular cells, and posterior synechiae

Page 40: Masquerade Syndrome

Treatment options of ciliary body melanoma

1. Iridocyclectomy - small or medium tumours

2. Enucleation - large tumours

3. Radiotherapy - selected cases

Page 41: Masquerade Syndrome

Uveal melanoma

Epidemiology: 4.9% of 450 enucleation specimens had ocular

inflammation initially Ocular Manifestations:

Episcleritis, AU, PU, endophthalmitis, panophthalmitis

Systemic Associations: May have features of metastatic melanoma

Page 42: Masquerade Syndrome

Choroidal melanoma• Most common primary intraocular tumour in adults

• Most common uveal melanoma - 80% of cases

• Presentation - sixth decade

• Prognosis - usually good

Page 43: Masquerade Syndrome

Choroidal melanoma (1)

• Brown, elevated, subretinal mass• Occasionally amelanotic• Double circulation

• Secondary retinal detachment • Choroidal folds

Page 44: Masquerade Syndrome

Choroidal melanoma (2)

• Surface orange pigment (lipofuscin) is common• Mushroom-shaped if breaks through Bruch’s membrane

• Ultrasound - acoustic hollowness, choroidal excavation and orbital shadowing

Page 45: Masquerade Syndrome

Treatment of choroidal melanoma

1. Brachytherapy - less than 10 mm elevation and 20 mm diameter

2. Charged particle irradiation - if unsuitable for brachytherapy

3. Transpupillary thermotherapy - selected small tumours

4. Trans-scleral local resection - carefully selected tumours less than 16 mm in diameter

5. Enucleation - very large tumours, particularly if useful vision lost

6. Exenteration - extraocular extension

Page 46: Masquerade Syndrome

LEUKAEMIAS :INTRODUCTION

Gp. Of neoplastic disorders ch. By abnormal proliferation of WBC.

Three types ALL- Children are affected AML- Worse prognosis,Adults more affected Chronic leukaemias – Elderly affected

Ocular findings in 28–75% with acute leukemia less with chronic

Page 47: Masquerade Syndrome

LEUKAEMIAS OCULAR FEATURES

SCH Iritis & Hypopyon Diffuse & Nodular iris thickening Hyphaema Orbital involvement Optic neuropathy

Page 48: Masquerade Syndrome

Anterior segment infiltration in acute myeloid leukemia (AML) presenting as hypopyon uveitis

Relapsing acute myeloid leukemia presenting as hypopyon uveitis Sapna P Hegde1, Atul T Ursekar2, Ajay A Chitale3

Page 49: Masquerade Syndrome

LEUKAEMIAS Retinopathy

Venous tortuosity & dilatation

Flame shaped H’ge & ROTH SPOTS Cotton wool spots Peripheral retinal

neovascularisation LEOPARD SPOT

RETINA

Page 50: Masquerade Syndrome

Leukemic infiltration of the retina

Masquerading as infectious chorioretinitis

Page 51: Masquerade Syndrome

Diagnostic Tests

Bone marrowperipheral blood smearaqueous cytology

Page 52: Masquerade Syndrome

JUVENILE XANTHOGRANULOMA

Vascular Tm. Affecting skin & eye

Important cause spontaneous hyphaema & seconary glaucoma

Epidemiology: 85% of skin lesions present before 1

year of age

Ocular Manifestations: Yellowish iris nodule or diffuse

thickening, heterochromia, spontaneous hyphema

Systemic Associations:Raised, reddish-yellowish skin lesions

Diagnosis iris biopsy or by finding similar lesions on the skin

Page 53: Masquerade Syndrome

Metastatic tumors Epidemiology :

Most common intraocular malignancy in adults

Ocular Manifestations: Usually bilateral, multifocal,

plateau-shaped, yellow posterior segment lesions with SRF; anterior segment: AU, iris nodules, NVI

Systemic Associations : Lung and breast carcinoma most

common primary sites Cutaneous melanoma most

common metastasis to retina

Page 54: Masquerade Syndrome

Long-standing peripheral rhegmatogenous retinal detachment

May produce a cellular reaction in the anterior or posterior chamber as well as PS.

Diagnostic Tests Ophthalmoscopy Ultrasound

Page 55: Masquerade Syndrome

Retained intraocular foreign body

Retained intraocular foreign body associated with trauma may cause persistent anterior and/ or posterior segment inflammation.

Diagnostic Tests: X-ray Ultrasound CT scan( should demonstrate the abnormality)

Page 56: Masquerade Syndrome

Retinitis pigmentosa

May present with vitreous cells and posterior subcapsular cataract The ‘‘bone spicule’’ pigment deposition in the retina,

attenuated retinal vessels, mottling and atrophy of the RPE, and waxy pallor of the optic nerve help to distinguish this disease from other disorders.

The diagnosis can be confirmed with an extinguished electroretinogram and ring scotoma on visual field testing.

Page 57: Masquerade Syndrome

Kruckenberg’s spindle in a patient with pigment dispersion syndrome that masqueraded as anterior uveitis.

Page 58: Masquerade Syndrome

Ocular ischemicsyndrome

Age (yr):50+ Signs of Inflammation

Cell Flare Redness

Diagnostic Tests: IVFA Carotid Doppler

Page 59: Masquerade Syndrome

Ocular Ischemic Syndrome

What percent carotid obstruction is typically required to cause OIS? 90%

Describe the symptoms Gradual visual loss Aching pain Prolonged recovery following bright light exposure

What are anterior segment findings? Iris neovascularization (67%) AC cellular reaction (20%)

Page 60: Masquerade Syndrome
Page 61: Masquerade Syndrome

Ocular Ischemic Syndrome Describe the posterior segment findings

Narrowed arteries Dilated, non-tortuous veins Mid-peripheral retinal hemorrhages, microaneurysms Neovascularization

What are the fluorescein angiographic findings? Delayed choroidal filling (60%) Delayed arteriovenous transit (95%) Vascular staining (85%)

What is the 5-year mortality rate and what is the most common cause of death? 40% Cardiovascular disease

Page 62: Masquerade Syndrome

85yo chronic pain and redness OD

Page 63: Masquerade Syndrome

Coats’ disease

Aspecific uveitis Vitreous infiltrates Fluorescein angiography

Page 64: Masquerade Syndrome

Presentation of Coats disease• First decade, more common in boys• Always unilateral

Visual loss and strabismus White fundus reflex (leukocoria)

Page 65: Masquerade Syndrome

Progression of Coats disease

• Retinal and subretinal hard exudation• Overlying vascular dilatation and tortuosity

• Slow progresssion of exudation• Exudative retinal detachment and retrolental mass

• May benefit from photocoagulation

• Treatment not beneficial • May mimic retinoblastoma

• Severe visual loss

Page 66: Masquerade Syndrome

FA of Coats disease

Vascular malformations are highlighted

Page 67: Masquerade Syndrome

Uveitis associated with medications

Page 68: Masquerade Syndrome

CONCLUSION

It is clear that a number of entities can masquerade as idiopathic uveitis, and in the absence of a correct diagnosis inappropriate therapy may be prescribed.

The diagnosis of a masquerade syndrome should therefore be considered in the evaluation of all patients with undiagnosed inflammatory eye disease

Page 69: Masquerade Syndrome

Thanks for your attention